The Effects of p-nonylphenol on the Myometrial Contractile Activity

ÖZATİK F. Y., Kaygisiz B., Erol K., Dundar Y., Onkol T., Sahin M. F.

Drug Research, vol.65, no.7, pp.388-392, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 65 Issue: 7
  • Publication Date: 2014
  • Doi Number: 10.1055/s-0034-1387717
  • Journal Name: Drug Research
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.388-392
  • Gazi University Affiliated: Yes


© Georg Thieme Verlag KG Stuttgart · New York.We aimed to investigate the effects and mechanisms of action of p-nonylphenol(p-NP) on uterine contractility in rats. The uterine tissues of female Sprague Dawley rats in diestrus were bathed in isolated organ bath. The effects of vehicle alone (0.1% ethanol), the positive control 17-β-E2 (10-5 M) and p-NP (10-9 M, 10-8 M, 10-7 M, 10-6 M) on spontaneous and KCl-induced uterine contractility of rats were studied. Also, the effects of p-NP in combination with actinomycin D (10-5 M) (gene transcription inhibitor), cycloheximide (10-4 M) (protein synthesis inhibitor), fulvestrant (10-6 M) (pure estrogen receptor antagonist), 2-hydroxy-5-nonanoylbenzamide (10-3 M) (compound 1b, anti-uterotrophic compound) on spontaneous uterine contractions, and with propranolol (20μM) (β-adrenoceptor antagonist) and noradrenaline (5μM) on KCl (40mM) induced contractions were investigated. p-NP exhibited a concentration-dependent inhibition on spontaneous uterine contractions. There was no significant difference between the highest p-NP concentration (10-6 M) and the positive control 17-β-E2 in terms of % inhibition (p>0.05). The inhibitory effect of p-NP (10-6 M) on spontaneous contractions was blocked by actinomycin D (p<0.001), cycloheximide (p<0.001), fulvestrant (p<0.001) and compound 1b (p<0.001). 17-β-E2 (10-5 M) exerted a higher inhibition % on KCl induced contractions than p-NP (10-6 M). The relaxant effect of p-NP on KCl-induced uterine contractions was inhibited by noradrenaline (p<0.05) but not by propranolol (p>0.05). We suggest that p-NP inhibited uterine contractions similar as 17-β-E2 and genomic pathways are involved and β-adrenoceptors might modulate the activity of p-NP. In addition, compound 1b showed an uterotonic activity and reversed the effect of p-NP.